Cargando…

Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors

Detalles Bibliográficos
Autores principales:	Li, Feng, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438967/ https://www.ncbi.nlm.nih.gov/pubmed/30937188 http://dx.doi.org/10.1038/s41392-019-0041-1

Ejemplares similares

CAR-T: a potential gene carrier targeting solid tumor immune microenvironment
por: Wang, Minjie, et al.
Publicado: (2021)

Puzzling mRNA: Alternative splicing fine-tunes specificity and function
por: Häfner, Sophia Julia
Publicado: (2019)

The interferon-γ receptor pathway: a new way to regulate CAR T cell-solid tumor cell adhesion
por: Hong, Lingjuan, et al.
Publicado: (2022)

Nr4a transcription factors limit CAR T cell function in solid tumors
por: Chen, Joyce, et al.
Publicado: (2019)

Tuning the rheostat of immune gene translation
por: Huang, Shuai
Publicado: (2023)

EpiMap: Fine-tuning integrative epigenomics maps to understand complex human regulatory genomic circuitry
por: Hoon, Dave S. B., et al.
Publicado: (2021)

Dynamic fine-tuning of CAR-T cell therapy
por: Trehin, Pierre V.M., et al.
Publicado: (2023)

New Strategies for the Treatment of Solid Tumors with CAR-T Cells
por: Zhang, Hao, et al.
Publicado: (2016)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Immune receptor mimicking hormone receptors: a new guarding strategy
por: Liu, Xueru, et al.
Publicado: (2023)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy
por: Peng, Xuerun, et al.
Publicado: (2021)

Step further towards targeted senolytic therapy: therapeutic potential of uPAR-CAR T cells for senescence-related diseases
por: Huang, Yujia, et al.
Publicado: (2020)

CAR T cells remain during long-term cancer remission
por: Barnes, Katharine
Publicado: (2022)

Targeting mitochondria as an anticancer strategy
por: Dong, Lanfeng, et al.
Publicado: (2019)

Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy
por: Zheng, Zhibo, et al.
Publicado: (2023)

CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
por: Martinez, Marina, et al.
Publicado: (2019)

ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity
por: Gan, Boyi
Publicado: (2022)

Efficient and versatile manipulation of the peripheral CD4(+) T-cell compartment by antigen targeting to DNGR-1/CLEC9A
por: Joffre, Olivier P, et al.
Publicado: (2010)

Barring the gates to the battleground: DDR1 promotes immune exclusion in solid tumors
por: Wagner, Dimitrios L., et al.
Publicado: (2022)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

WeiTsing: a new face of Ca(2+)-permeable channels in plant immunity
por: Wang, Feng-Zhu, et al.
Publicado: (2023)

Dark side of cyanobacteria: searching for strategies to control blooms
por: Huertas, María José, et al.
Publicado: (2021)

Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
por: Freeman, Andrew J., et al.
Publicado: (2020)

Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors
por: Hirobe, Sachiko, et al.
Publicado: (2022)

Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells
por: Charo, Jehad, et al.
Publicado: (2021)

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein
por: Wang, Junzhi
Publicado: (2020)

Gene modification strategies for next-generation CAR T cells against solid cancers
por: Tian, Yonggui, et al.
Publicado: (2020)

A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors
por: Liao, Weiting, et al.
Publicado: (2023)

Fighting the enemy: one health approach against microbial resistance
por: Udaondo, Zulema, et al.
Publicado: (2020)

Microbial antibiotics take the lead in the fight against plant pathogens
por: Roca, Amalia, et al.
Publicado: (2022)

Radiotherapy and the tumor microenvironment: The “macro” picture
por: Walton, Emma Louise
Publicado: (2017)

The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019)

Induction of membraneless organelles as a strategy for HIV-1 post-nuclear entry steps
por: Zhou, Sheng, et al.
Publicado: (2023)

Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical Studies
por: Lee, Boon kiat, et al.
Publicado: (2022)

Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)

Switchable targeting of solid tumors by BsCAR T cells
por: Stepanov, Alexey V., et al.
Publicado: (2022)

PI3K-PANK4: a new target for de novo synthesis of coenzyme A
por: Guan, Jizhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_963hjvfvaq1djrfebu9nli3pcf